Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Free Subscription


2 Drugs Aging
1 J Bone Miner Res
3 Osteoporos Int
1 PLoS Genet

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Drugs Aging

  1. HONVO G, Bannuru RR, Bruyere O, Rannou F, et al
    Recommendations for the Reporting of Harms in Manuscripts on Clinical Trials Assessing Osteoarthritis Drugs: A Consensus Statement from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases
    Drugs Aging. 2019;36.
    PubMed     Text format     Abstract available

  2. SOLLING ASK, Harslof T, Langdahl B
    Current Status of Bone-Forming Therapies for the Management of Osteoporosis.
    Drugs Aging. 2019 May 8. pii: 10.1007/s40266-019-00675.
    PubMed     Text format     Abstract available

    J Bone Miner Res

  3. ZENG Q, Li N, Wang Q, Feng J, et al
    The prevalence of osteoporosis in China, a nationwide, multicenter DXA survey.
    J Bone Miner Res. 2019 May 8. doi: 10.1002/jbmr.3757.
    PubMed     Text format     Abstract available

    Osteoporos Int

  4. HOPMAN WM, Berger C, Joseph L, Morin SN, et al
    Longitudinal assessment of health-related quality of life in osteoporosis: data from the population-based Canadian Multicentre Osteoporosis Study.
    Osteoporos Int. 2019 May 8. pii: 10.1007/s00198-019-05000.
    PubMed     Text format     Abstract available

  5. BALASUBRAMANIAN A, Zhang J, Chen L, Wenkert D, et al
    Risk of subsequent fracture after prior fracture among older women.
    Osteoporos Int. 2018 Nov 19. pii: 10.1007/s00198-018-4732.
    PubMed     Text format     Abstract available

  6. CHANDLER H, Brooks DJ, Hattersley G, Bouxsein ML, et al
    Abaloparatide increases bone mineral density and bone strength in ovariectomized rabbits with glucocorticoid-induced osteopenia.
    Osteoporos Int. 2019 May 3. pii: 10.1007/s00198-019-04999.
    PubMed     Text format     Abstract available

    PLoS Genet

    On the utilization of polygenic risk scores for therapeutic targeting.
    PLoS Genet. 2019;15:e1008060.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Osteoporosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.